Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of dual H3/M2 antagonists in the treatment of cognition deficit disorders

Use of dual H3/M2 antagonists in the treatment of cognition deficit disorders

US Patent 6906081 · Granted Jun 14, 2005

Estimated economic value: $160,933,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sulfopropanoic acid derivatives for treating neurodegenerative disorders2025
Compositions and methods for treating and preventing neurodegenerative disorders2025
Methods for treating neurodegenerative disorders2024
Methods for treating neurodegenerative disorders2024
Methods of treating neurodegenerative disorders in a particular population2021
Methods for treating neurodegenerative disorders2021
Compositions and methods for treating and preventing neurodegenerative disorders2021
Aminopyrazine compounds with A2A antagonist properties2020
Compositions and methods for treating and preventing neurodegenerative disorders2020
Methods for treating neurological disorders2019
Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulators2016
Quinolines and aza-quinolines as CRTH2 receptor modulators2016